Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals

Jianquan Zhu, Wen‐Zhao Zhong, Rong Li, Xu‐Chao Zhang, Ailin Guo, Yi-fang Zhang, She-Juan An, Tony Mok, Yi‐Long Wu

Cancer Letters · 2008 · 127 citations · 34 references

Concepts

References

34